Indegene iON Overview

Indegene-Ion offers healthcare solutions using AI and data analytics. This platform improves efficiency and patient outcomes for healthcare providers.

Use Cases

Customers recommend Business Development, Engaging And Following Up, Direct Marketing, as the business use cases that they have been most satisfied with while using Indegene iON.

Other use cases:

  • Personalized Marketing
  • Digital Marketing
  • International Marketing
  • Public Relations
  • Advertisement
  • Content Management
See all use cases See less use cases

Business Priorities

Launch New Products is the most popular business priority that customers and associates have achieved using Indegene iON.

Other priorities:

See all business priorities See less business priorities

Indegene iON Use-Cases and Business Priorities: Customer Satisfaction Data

Indegene iON works with different mediums / channels such as Omnichannel.

Indegene iON Customer wins, Customer success stories, Case studies

Why is Indegene iON the best choice for Business Development?

How can Indegene iON enhance your Engaging And Following Up process?

Indegene iON Features

  • Low
  • Medium
  • High
FEATURE RATINGS AND REVIEWS
Analytics

3.93/5 ★

Read Reviews (9)
Custom Reports

3.56/5 ★

Read Reviews (6)
CAPABILITIES RATINGS AND REVIEWS
Analytics

3.93/5 ★

Read Reviews (9)
Custom Reports

3.56/5 ★

Read Reviews (6)

Software Failure Risk Guidance

?

for Indegene iON

Top Failure Risks for Indegene iON

Indegene News

Financial

Indegene Q3 results: Revenue surges 31% to 942 crore but profit, margins dip

Indegene's Q3 FY26 results show a 30.8% revenue increase to 942 crore, marking its first $100 million-plus revenue quarter. Despite this, net profit fell 6.2% to 102.9 crore, and operating margins narrowed to 17%. Key achievements include three customers surpassing $25 million in annual revenue. Recent acquisitions of BioPharm and Warn & Co aim to enhance domain expertise.

Read more →
Financial

Indegene Board to Approve Q3 2026 Financial Results

Indegene's Board of Directors will meet on January 29, 2026, to review and approve the unaudited financial results for Q3 2026. The meeting will also address share allotment under the RSU Scheme 2020. The trading window for company securities is closed until 48 hours after the results are declared.

Read more →
Partnership

Indegene Selects Verified Market Research to Gain Strategic Insight into the Conjunctivitis Allergy Market

Indegene partnered with Verified Market Research to obtain strategic insights into the conjunctivitis allergy market. This collaboration aimed to support Indegene's advisory role for a client by providing detailed market sizing, segmentation, and competitive analysis. The insights helped shape the client's portfolio expansion strategy, demonstrating Indegene's commitment to delivering precise and actionable data.

Read more →
Company

Indegene expands its consulting practice to support life sciences organizations

Indegene has expanded its consulting practice to assist life sciences organizations in managing large-scale transformations. The company has appointed Gobin Chandra as the head of its Integrated Consulting Practice. This expansion includes acquiring UK-based WARN & Co. to enhance its transformation consulting capabilities.

Read more →

Indegene Profile

Company Name

Indegene

Company Website

https://www.indegene.com/

HQ Location

Princeton, New Jersey

Employees

5001-10000

Social

Facebook Linkedin Twitter

Financials

PRIVATE